A new CTTI publication, published in the Journal of the American College of Cardiology, investigates the use of preventive, high-intensity statins among patients diagnosed with atherosclerotic cardiovascular disease (ASCVD). The study, which used pharmacy and medical claims data from a commercial health plan, found substantial underuse of statins among insured ASCVD patients. Most notably, younger patients and women were among those less likely to be prescribed any statin. In those prescribed a statin, women and older patients were less likely to receive high-intensity statins. This paper was based on exploratory work done by CTTI with Duke and HealthCore as background to inform a potential randomized intervention to improve the use of guideline recommended high-intensity statins.